Neuroendocrine control of natural killer cell function through the checkpoint molecule PD-1

被引：0
|
作者：
Justine Devulder
Anne Tsicopoulos
Catherine Duez
机构：
[1] Institut National de la Santé Et de la Recherche Médicale,Pulmonary Immunity
[2] U1019,Institut Pasteur de Lille
[3] Center for Infection and Immunity of Lille,undefined
[4] CNRS UMR 8204,undefined
[5] Univ Lille Nord de France,undefined
[6] Clinique des Maladies Respiratoires et Centre Hospitalier Régional et Universitaire de Lille,undefined
来源：
Cellular & Molecular Immunology | 2019年 / 16卷
关键词：
Neuroendocrine Control; MCMV Infection; Quatrini; Murine Cytomegalovirus; Reduce Pathogen Burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 111
页数：2
相关论文
共 50 条
  • [1] Neuroendocrine control of natural killer cell function through the checkpoint molecule PD-1
    Devulder, Justine
    Tsicopoulos, Anne
    Duez, Catherine
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (02) : 109 - 111
  • [2] The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
    Quatrini, Linda
    Mariotti, Francesca Romana
    Munari, Enrico
    Tumino, Nicola
    Vacca, Paola
    Moretta, Lorenzo
    CANCERS, 2020, 12 (11) : 1 - 21
  • [3] Neuroendocrine regulation of natural killer cell function.
    Morgan, FW
    Callewaert, DM
    FASEB JOURNAL, 1999, 13 (05): : A961 - A961
  • [4] Covalent small-molecule inhibitors of the PD-1/PD-L1 immune checkpoint
    Maslanka, A.
    Kitel, R.
    Konopka, J.
    Skalniak, L.
    FEBS OPEN BIO, 2024, 14 : 329 - 330
  • [5] The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
    Allison L. Balasko
    Monika M. Kowatsch
    Colin Graydon
    Julie Lajoie
    Keith R. Fowke
    Scientific Reports, 13
  • [6] The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
    Balasko, Allison L.
    Kowatsch, Monika M.
    Graydon, Colin
    Lajoie, Julie
    Fowke, Keith R.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
    Pottayil G. Sasikumar
    Murali Ramachandra
    BioDrugs, 2018, 32 : 481 - 497
  • [8] Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
    Sasikumar, Pottayil G.
    Ramachandra, Murali
    BIODRUGS, 2018, 32 (05) : 481 - 497
  • [9] Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1B
    Nishimura, Yoshito
    Wake, Hidenori
    Teshigawara, Kiyoshi
    Wang, Dengli
    Sakaguchi, Masakiyo
    Otsuka, Fumio
    Nishibori, Masahiro
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (03):
  • [10] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345